1 iastolic volume, high ejection fraction, and high cardiac output.

2 0 mm Hg or below, accompanied by a normal or high cardiac output.

3 y pulmonary hypertension (PPH) who developed high cardiac outputs.

4  with eccentric remodeling and fibrosis, and high cardiac output, a unique constellation of findings

5 th severe hepatic vascular malformations and high cardiac output, administration of bevacizumab was a

6 nd clinical relevance despite anemia-induced high cardiac output and less severely elevated pulmonary

7 .0+/-0.2 versus 2.7+/-0.3 mg/g; P<0.01), and high cardiac output (cardiac index 3.2+/-0.4 versus 2.4+

8 ular response to ANP differs in animals with high cardiac output compared with control animals.

9 es have a high .VO(2,max) due primarily to a high cardiac output from a large compliant cardiac chamb

10 ure and may be driven by left heart failure, high cardiac output from arteriovenous fistula, hypoxic

11  Excessive prostacyclin in PPH can lead to a high cardiac output state, suggesting it has important p

12 s in lethal embryonic heart failure due to a high-cardiac-output state.

13 hronic prostacyclin therapy who presented in high cardiac output states.